GSK3B and rheumatoid arthritis: Another study in a mouse model of rheumatoid arthritis shows that GSK-3β inhibitors suppress inflammatory responses by downregulating the NF-kB signaling pathway, along with downregulating the expression of c-Jun N-terminal kinase (JNK), c-jun, activating transcription factor (ATF) 2, and p-38 [77].